Brick by brick, and startup by startup, the New York biotech scene is slowly being built up. More startup incubators are either up, or in development, than ever before. Several pieces necessary to a functional life sciences ecosystem are now in place, and many other milestones will simply take time to develop and succeed. Yet industry and government leaders, investors, and entrepreneurs can’t get complacent—there is much more that New York can do, right now, to gain ground on other hubs and further establish the region as a top center for life science. If the right progress is made, 2018 could be a signature year for the city—or, if progress proves elusive, the momentum could slip away.
Co-Chair, LifeSci NYC Advisory Council
Vice President, Corporate Development & Strategy, Bluerock Therapeutics
VP Venture Capital, Pfizer
Senior Vice President, Mount Sinai Innovation Partners
Senior Principal - Science & Technology, Alexandria Venture Investments
Partner, Technology Consulting, RSM US
Founder, CEO, & Editor in Chief, Xconomy
Biocrossroads • UT Health San Antonio
VENTURE CAPITAL MEMBERS
Avalon Ventures • Flagship Pioneering • RA Capital • SR One • Third Rock Ventures
LIFE SCIENCE MEMBERS
Arrowhead Pharmaceuticals • Bayer • Foundation Medicine • Health Advances • Shire
We’ll bring together a small group of influential New York life sciences leaders to host an interactive, town hall-style talk to explore these important topics.